Ozempics main ingredient, known as semaglutide, is in Wegovy, which was approved by the FDA in 2021 to treat obesity
Tirzepatide at 10 mg and 15 mg doses was superior to placebo in reducing urine albumin-to-creatinine ratio
Immediate consultation is warranted if you are considering extending your dosing interval to every other week, as this represents a significant deviation from FDA-approved prescribing information
As of January 5, 2026, there are 3,063 active lawsuits against Novo Nordisk and other GLP-1 drug manufacturers, according to court documents
The metabolic effects of tirzepatide interact with the hormonal environment created by estrogen, progesterone, and testosterone replacement
American Journal of Geriatric Psychiatry